» Authors » Pascal Kurosinski

Pascal Kurosinski

Explore the profile of Pascal Kurosinski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 163
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Falzon D, Timimi H, Kurosinski P, Migliori G, Van Gemert W, Denkinger C, et al.
Eur Respir J . 2016 May; 48(1):29-45. PMID: 27230443
In 2014, the World Health Organization (WHO) developed the End TB Strategy in response to a World Health Assembly Resolution requesting Member States to end the worldwide epidemic of tuberculosis...
2.
Kulic L, Kurosinski P, Chen F, Tracy J, Mohajeri M, Li H, et al.
Neurobiol Dis . 2005 Nov; 22(1):50-6. PMID: 16289870
Amyloid beta-peptide (Abeta) containing plaques and neurofibrillary tangles (NFT) are the two major histopathological hallmarks of Alzheimer's disease (AD). According to the amyloid cascade hypothesis, deposition of Abeta is an...
3.
Kins S, Kurosinski P, Nitsch R, Gotz J
Am J Pathol . 2003 Aug; 163(3):833-43. PMID: 12937125
A reduced activity of protein phosphatase 2A (PP2A) has been shown in brains of patients with Alzheimer's disease (AD), a neurodegenerative disorder characterized histopathologically by amyloid plaques and neurofibrillary tangles....
4.
Kurosinski P, Gotz J
Arch Neurol . 2002 Oct; 59(10):1524-8. PMID: 12374489
Glial cells have long been considered to play roles in the nervous system that are unexciting compared with those of neurons. They provide neurons with nutrients, guide migrating neurons and...
5.
Kurosinski P, Guggisberg M, Gotz J
Trends Mol Med . 2002 Feb; 8(1):3-5. PMID: 11796255
Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most common neurodegenerative disorders in humans. They are characterized by insoluble protein deposits; beta-amyloid plaques and tau-containing neurofibrillary lesions in...